Tom Brady Is Newest Face of GLP-1s, Joining Telehealth Startup

Jan. 12, 2026, 11:00 AM UTC

Tom Brady is bringing together two of America’s favorite pastimes: football and weight-loss drugs.

The seven-time Super Bowl champion is the new chief wellness officer of eMed, a digital health startup that helps companies manage the high costs associated with covering popular weight-loss drugs for their employees. Brady’s role is to help build awareness for the company, which started out selling Covid tests, but pivoted into weight loss last year. He’ll also serve on the board of directors.

“There are a lot of companies out there, but eMed stood out because they’re building something different; high-quality care, best-in-class service, ...

Learn more about Bloomberg Law or Log In to keep reading:

See Breaking News in Context

Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.

Already a subscriber?

Log in to keep reading or access research tools and resources.